In stroke and GCI animal models, expression and activity of aromatase significantly enhance in activated astrocytes, while central knockdown/knockout or inhibitor of aromatase deteriorates the brain injury [8, 14–16]. This evidence concerns the gene CYP19A1 and Stroke.